Grožio ir sveikatos studija, MB - financials and debts

Company age: 2 y. 5 mo.

Update

Grožio ir sveikatos studija - Company finances

EUR
2024
From: 2024-06-03
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 10,094 17,876
Profit before tax - -
Net profit 1,803 948
Equity 1,805 2,531
Liabilities 11,808 10,000
Non-current assets 8,505 7,702
Current assets 5,108 6,766
Total assets 13,613 14,468
Taxes paid
STI taxes 70 95
Financial indicators
Revenue change y/y - +77.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 13.2% 6.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 99.9% 37.5%
Profit margin Net profit margin. Shows the overall profitability of the company. 17.9% 5.3%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 6.5 4.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Grožio ir sveikatos studija - Social security debts

The company had no debts to Sodra

Grožio ir sveikatos studija - VMI tax arrears

From To Overdue, €
2025-07-01 2025-07-20 0.03

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Grožio ir sveikatos studija, MB (code 306803311) is a Lithuanian small partnership engaged in hairdressing and barber activities. In 2025, the latest financial year, the company generated revenue of EUR 17.9K and net profit of EUR 948, with a profit margin of 5.3%. Revenue increased by 77.1% year on year from EUR 10.1K in 2024, showing a clear expansion in sales. At the same time, net profit declined from EUR 1.8K in 2024, indicating that profitability weakened despite the stronger turnover. Over the two-year period, the business moved from a shorter 211-day 2024 period to a full 364-day 2025 year, which should be considered when comparing results. At the end of 2025, total assets stood at EUR 14.5K, equity at EUR 2.5K, and liabilities at EUR 10.0K. Long-term assets were EUR 7.7K and short-term assets EUR 6.8K. The company’s asset turnover was 1.24x, with a debt-to-equity ratio of 3.95 and an equity ratio of 17.5%.